Pamela Stephenson, Chief Commercial Officer at ALBIREO PHARMA, INC. (ALBO), sold 102 shares at $43.80 ($4K) on 2023-01-23, disclosed to the SEC on 2023-01-23.
Scheduled sale ($4k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ZYNE | SELL | 2023-06-15 | $40 | — | Filing → |
| ALBO | SELL | 2023-01-20 | $156K | — | Filing → |
| ALBO | SELL | 2022-12-27 | $9K | — | Filing → |